Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02938793
Title Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Greenville Health System
Indications
Therapies
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Greenville Health System Cancer Institute RECRUITING Greenville South Carolina 29605 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field